We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

Antioxidant Supplementation and Risk of Skin Cancers—Reply

Maryam M. Asgari, MD, MPH; Sonia S. Maruti, MSc, ScD; Emily White, PhD
Arch Dermatol. 2010;146(5):568. doi:10.1001/archdermatol.2010.84.
Text Size: A A A
Published online


In reply

In their letter, Ezzedine et al suggest that VITAL, an observational study, and SU.VI.MAX, a randomized clinical trial, came to different conclusions about the relationship between supplement use and risk of melanoma mainly because of uncontrolled confounding in the observational study. We agree with Ezzedine et al that randomized trials, by design, are better protected against confounding than observational studies. However, we believe that we controlled for the factors that are associated with melanoma risk in VITAL. Moreover, we had increased precision, given that we had more cases of melanoma (n = 461) in our sample than were studied in the SU.VI.MAX trial (n = 25). Additionally, we obtained the same result of no association after examining the use of supplements and melanoma risk in several different ways, and our findings are robust in that they are supported by the results of other observational studies. For many questions of clinical importance, well-designed observational studies have constituted the best available evidence.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles